9th Annual Clinical Trials Summit 2018
22 May 2018
9:00 AM
Mumbai
331 views
Terms & Conditions
- Tickets once booked cannot be exchanged or refunded.
Description
Event Description:
“A critical guide for
successfully conducting clinical trials”
Virtue Insight welcomes you to attend the 9th Annual Clinical Trials Summit 2018, which is going to be held
in Mumbai on 22nd May 2018. We
cordially invite all the participants who are interested in sharing their
knowledge and research in the arena of Clinical Trials. 9th Annual Clinical
Trials Summit 2018 anticipates participants around the globe with thought
provoking Keynote lectures, Oral Presentations and Poster Presentations. This
is an excellent opportunity for the delegates from Universities and Institutes
to interact with the world class Scientists. The main theme of the conference
is to positively learn and educate about clinical trials is essential, if only
to counter more negative perceptions.
KEY SPEAKERS:
·
OMPRAKASH S. SADHWANI, Joint Commissioner (Nashik Division), Food and Drugs Administration (M.S.)
·
K. BANGARURAJAN, Joint Drugs Controller (INDIA), CDSCO (HQ)
·
NILIMA A. KSHIRSAGAR, National Chair Clinical Pharmacology, ICMR Govt. of India
·
MUZAFFAR AHMAD, Member Strategic Advisory Board on Health Millenium
Alliance (Govt of India) and Member Council of India
·
JAMILA JOSEPH, Senior Vice President and Head Clinical Research
Services, Reliance Life Sciences
·
DEVEN V PARMAR, Vice President & Head Clinical R&D, Cadila Healthcare
·
ARUN BHATT,
Consultant - Clinical Research & Development
·
SANDESH SAWANT, Director and Head Clinical Trials, Cipla
·
CHIRAG TRIVEDI, Director & Head of Clinical Study Unit, Sanofi-aventis
·
DILIP PAWAR, Director and Head - Clinical Development and Medical
- Emerging Market including APAC, Merck
Sharp & Dohme
·
SHIRAZ KANDAWALLA, Associate Director - Regulatory Affairs, Abbott
·
BINDU AJIT,
Program Director, Biocon Academy
·
AMMAR RAZA,
Country Medical Director & Chief Medical Office, Allergan
·
KEDAR SUVARNAPATHAKI, Head - Regulatory Affairs & IP, Boehringer Ingelheim
·
SIDDHARTH DESHPANDE, Assistant Professor Department of Clinical
Pharmacology, KEM Hospital
·
AGAM SHAH,
Head Clinical Operations, Wockhardt
·
JYOTSNA PATWARDHAN, Head Development QA, Novartis
·
CHIRAG TELI, Head of Medical Services, Alkem Laboratories
·
AMEY MANE,
General Manager - Medical Affairs, Janssen
India (Pharmaceutical companies of Johnson & Johnson)
·
SUJAY SURESH KULKARNI, Senior Manager - Medical and Regulatory Affairs, GSK
·
PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research
·
PRASHANT BODHE, Director, CliniSearch
KEY THEMES:
·
Current
challenges and regulations for clinical trials in India
·
Having
a positive impact on overall market to globalize trials and growth in new
product development in emerging countries
·
Formulating
a risk-based inspection plan for advanced clinical trials
·
New
tools and technologies for data capture for clinical trials
·
Developing
effective partnerships and vendor relationships
·
Necessary
strategies to implement the maximize value of the collaboration.
·
Patient
and clinical site centricity: Optimising the end users, patients and the
clinical sites
·
Encouraging
data analytics for next-generation clinical trials
·
EHR
(Electronic Health Records) for clinical research facility
·
Recent
guidelines issued by FDA on the use of EHR data
·
Major
roles of clinical pharmacology in drug discovery and development
·
New
clinical trials rules and its impact
·
Current
requirements of Indian Clinical Trial Application (CTA) and how this will
change with the new clinical trial regulation
·
Regulatory
considerations in India and south-east Asia
·
Be part
of a major networking opportunity
WHO SHOULD ATTEND:
CEO's,
CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:
Clinical
Research & Development, Clinical Research Services, Clinical Operations,
Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs,
Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study
Design, Safety Surveillance, Subject Recruitment, E-Clinical Systems
*Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 GST (18%) per delegate)
·
Conference Sponsor & Exhibition Stall( Booth) or
a paid Speaker Slot are also
available.
Get
more from the event, with a broader scope bringing the whole communications
value chain together. Enjoy and make the best out of our dedicated networking
time, meet the leading international vendors showcasing the products of
tomorrow in the co-located exhibition. Expand your knowledge of the latest
business models and strategies in the high-level conference.
About - 9th Annual Clinical Trials Summit 2018
Event Description:
“A critical guide for
successfully conducting clinical trials”
Virtue Insight welcomes you to attend the 9th Annual Clinical Trials Summit 2018, which is going to be held
in Mumbai on 22nd May 2018. We
cordially invite all the participants who are interested in sharing their
knowledge and research in the arena of Clinical Trials. 9th Annual Clinical
Trials Summit 2018 anticipates participants around the globe with thought
provoking Keynote lectures, Oral Presentations and Poster Presentations. This
is an excellent opportunity for the delegates from Universities and Institutes
to interact with the world class Scientists. The main theme of the conference
is to positively learn and educate about clinical trials is essential, if only
to counter more negative perceptions.
KEY SPEAKERS:
·
OMPRAKASH S. SADHWANI, Joint Commissioner (Nashik Division), Food and Drugs Administration (M.S.)
·
K. BANGARURAJAN, Joint Drugs Controller (INDIA), CDSCO (HQ)
·
NILIMA A. KSHIRSAGAR, National Chair Clinical Pharmacology, ICMR Govt. of India
·
MUZAFFAR AHMAD, Member Strategic Advisory Board on Health Millenium
Alliance (Govt of India) and Member Council of India
·
JAMILA JOSEPH, Senior Vice President and Head Clinical Research
Services, Reliance Life Sciences
·
DEVEN V PARMAR, Vice President & Head Clinical R&D, Cadila Healthcare
·
ARUN BHATT,
Consultant - Clinical Research & Development
·
SANDESH SAWANT, Director and Head Clinical Trials, Cipla
·
CHIRAG TRIVEDI, Director & Head of Clinical Study Unit, Sanofi-aventis
·
DILIP PAWAR, Director and Head - Clinical Development and Medical
- Emerging Market including APAC, Merck
Sharp & Dohme
·
SHIRAZ KANDAWALLA, Associate Director - Regulatory Affairs, Abbott
·
BINDU AJIT,
Program Director, Biocon Academy
·
AMMAR RAZA,
Country Medical Director & Chief Medical Office, Allergan
·
KEDAR SUVARNAPATHAKI, Head - Regulatory Affairs & IP, Boehringer Ingelheim
·
SIDDHARTH DESHPANDE, Assistant Professor Department of Clinical
Pharmacology, KEM Hospital
·
AGAM SHAH,
Head Clinical Operations, Wockhardt
·
JYOTSNA PATWARDHAN, Head Development QA, Novartis
·
CHIRAG TELI, Head of Medical Services, Alkem Laboratories
·
AMEY MANE,
General Manager - Medical Affairs, Janssen
India (Pharmaceutical companies of Johnson & Johnson)
·
SUJAY SURESH KULKARNI, Senior Manager - Medical and Regulatory Affairs, GSK
·
PRANJAL BORDOLOI, AVP - Medical Affairs and Pharmacovigilance, Veeda Clinical Research
·
PRASHANT BODHE, Director, CliniSearch
KEY THEMES:
·
Current
challenges and regulations for clinical trials in India
·
Having
a positive impact on overall market to globalize trials and growth in new
product development in emerging countries
·
Formulating
a risk-based inspection plan for advanced clinical trials
·
New
tools and technologies for data capture for clinical trials
·
Developing
effective partnerships and vendor relationships
·
Necessary
strategies to implement the maximize value of the collaboration.
·
Patient
and clinical site centricity: Optimising the end users, patients and the
clinical sites
·
Encouraging
data analytics for next-generation clinical trials
·
EHR
(Electronic Health Records) for clinical research facility
·
Recent
guidelines issued by FDA on the use of EHR data
·
Major
roles of clinical pharmacology in drug discovery and development
·
New
clinical trials rules and its impact
·
Current
requirements of Indian Clinical Trial Application (CTA) and how this will
change with the new clinical trial regulation
·
Regulatory
considerations in India and south-east Asia
·
Be part
of a major networking opportunity
WHO SHOULD ATTEND:
CEO's,
CTO's, CIO's, Presidents, Vice Presidents, Directors Heads & Managers of:
Clinical
Research & Development, Clinical Research Services, Clinical Operations,
Clinical Data Management, Clinical IT, Clinical Trials, Medical Affairs,
Regulatory Affairs, Compliance, Quality control / Assurance/GCP, Clinical Study
Design, Safety Surveillance, Subject Recruitment, E-Clinical Systems
*Spot Registration on the day of the Conference – 1 Day Conference - (INR 8,000 GST (18%) per delegate)
·
Conference Sponsor & Exhibition Stall( Booth) or
a paid Speaker Slot are also
available.
Get
more from the event, with a broader scope bringing the whole communications
value chain together. Enjoy and make the best out of our dedicated networking
time, meet the leading international vendors showcasing the products of
tomorrow in the co-located exhibition. Expand your knowledge of the latest
business models and strategies in the high-level conference.
EVENTS
Need help? Call Support : 9650400559
How to use Tickets
- After submitting payment for your ticket, you are our guest and you will on guest list of event organizer
- You are required to show your event ticket at event venue
- That’s it! Enjoy your event. Happy Ticketing
Benefits of buying from Showwoo
- We are trusted by many of event organizers and customers for providing outstanding services